CTC Detection Rate in SCCHN With a in Vivo Device

Not Applicable

• Conditions: Squamous Cell Carcinoma of the Head and Neck; Circulating Tumor Cell

• Registration Number: NCT03071900
• Lead Sponsor: Nanjing Tongren Hospital

Brief Summary

Detection rate and isolation yield of CTC is low in squamous cell carcinoma of head and neck (SCCHN) with in vitro approaches rely on limited sample volumes. In this study, we applied a new method, the CellCollector, which could capture CTC in vivo from peripheral blood.

Detailed Description

Not available

Study Timeline

• Study Start: 2016-06-22
• Status Verified: 2017-03
• Study First Submitted: 2017-03-01
• Study First Submitted QC: 2017-03-01
• Last Update Submitted: 2017-03-01
• Study First Posted: 2017-03-07
• Last Update Posted: 2017-03-07
• Primary Completion: 2017-03-15
• Study Completion: 2017-04-20

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 50

Inclusion Criteria

• SCCHN confirmed with clinical examination
• Have agreed to undergo CTC analysis in vivo;
• ECOG：0-2

Exclusion Criteria

• the other cancer types

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
CTC isolation	9 month	Isolate circulating tumor cells in vivo with CellCollector

Trial Locations

Locations (1)

Nanjing Tongren Hospital; 🇨🇳 Nanjing, Jiangsu, China